GSC
VRDN icon

Ground Swell Capital’s Viridian Therapeutics VRDN Stock Holding History

Ground Swell Capital’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$7K Buy
+7
New +$8.26K 0.01% 1276

Other funds holding VRDN

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Ground Swell Capital's VRDN Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Viridian Therapeutics (VRDN) in Q3 2014: 7 shares worth $7K. The stake represents 0.01% of the portfolio and ranks #1276 among its holdings.

5 funds tracked by Wall St. Rank hold VRDN as of Q3 2014.

  • Ground Swell Capital held 7 shares of Viridian Therapeutics worth $7K as of Q3 2014.
  • Viridian Therapeutics was a new Ground Swell Capital position in Q3 2014.
  • Viridian Therapeutics made up 0.01% of Ground Swell Capital's portfolio in Q3 2014, its #1276 holding.
  • 5 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.